AZN

#5576
AstraZeneca PLC
202.75 USD
-0.61%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
202.30
202.92
Year Range
66.16
212.71
Daily Change
-0.61%
Monthly Change
+6.27%
6 month change
+139.83%
Year Change
+203.56%
Previous Close
204.00
Open
202.59
Bid
Ask
Low
202.30
High
202.92
Volume
298
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 96 K
  • Founded 1999
  • CEO Pascal Soriot
  • Website www.astrazeneca.com
  • Headquarter United Kingdom
  • FIGI BBG000BZ0DK8
  • Industry Technology
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

AstraZeneca PLC - American Depositary Shares

AstraZeneca plc is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, UK; Gothenburg, Sweden; and Gaithersburg, Maryland, US. AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje.

News